American Biogenetic Sciences files fibrinogen test for clearance:
This article was originally published in Clinica
American Biogenetic Sciences has filed a 510(k) application to the FDA for its functional intact fibrinogen test for the quantitative determination of fibrinogen in human plasma. American Biogenetic Sciences, based in Copiague, New York, has moved its R&D operations into BioSquare research and business park in Boston, Massachusetts. BioSquare was developed by Boston University and Boston Medical Center.